Brain-like organoids with AD mutations in the APP or MAPT genes, or those exposed to amyloid molecules, are currently used to model AD ([5,157]; iPSC-derived organoid with fAD mutations [158,159]). The gene discussed is MAPT; the disease is Alzheimer disease.